SUMMARY
ments. Each compartment had a volume of 1 ml and was separated from the other by a dialysis membrane as described previously (Dale and Nilsen, 1984b) . Equilibrium was achieved within 10 h for the examined drugs, and binding was stable for a least 24 h Nilsen, 1984a, 1986b) .
Distribution dialysis was performed at 23 ± 1 °C and is described in detail elsewhere (Dale and Nilsen, 1986a) . Briefly, Plexiglass cells with three compartments (each of 1 ml) were separated by dialysis membranes; one compart-ment for serum, one for buffer and one for liver cytosol, respectively. Binding and distribution were stable from 16 to at least 24 h. Both equilibrium and distribution dialysis were run for 18 h, and the cells were gently shaken during this period.
[
14 C]-labelled drug isotope dissolved in ethanol was added to the buffer compartment to achieve initial drug concentration of 2.25 umol litre" 1 in all experiments performed at 23 ± 1 °C. In the experiments performed at 37 ± 2 °C, drug concentrations in the upper therapeutic ranges for phenytoin, warfarin and diazepam were used: 85, 10 and 2.25 umol litre" 1 , respectively. The purity of the isotopes (always more than 98%) and their stability during dialysis were shown by thin layer chromatography or gas-liquid chromatography as described previously Nilsen, 1984a, 1986a) .
Aliquots (100 ul) were drawn from each compartment after dialysis for determination of radioactivity. Drug concentrations were calculated from the distribution of labelled compound, radioactive recovery and added amount of drug. Protein concentrations and pH were measured before and immediately after terminated dialysis Nilsen, 1984a, 1986a) .
The influence of isoflurane on drug binding and distribution was determined by placing the dialysis cells in a gas-tight glass-dessicator (Dale and Nilsen, 1984a) into which the anaesthetic was delivered by a calibrated vaporizer (Cyprane Ltd, U.K.). Isoflurane concentrations (±10% of the given values) were measured before, during and immediately before terminating the dialysis by the same gas-liquid chromatographic procedure as described for halothane and enflurane (Dale and Nilsen, 1984a) .
The degree of binding was calculated as the free fraction in the clinically relevant studies (Dale and Nilsen, 1984a) :
( 1) or as binding capacity (n/K D ) according to mass law expressions (Goldstein, Aronow and Kalman, 1974) for the studies performed on human serum albumin as discussed previously (Dale and Nilsen, 1986b) :
or as binding ratio (B/F) according to equation (2) when binding to serum and cytosol was assessed simultaneously (Dale and Nilsen, 1986a) . B, F and P denote the molar concentrations of bound and free drug and protein, respectively, n = number of binding sites and Kn = dissociation constant. Distribution was described as the ratio of drug bound to cytosol (B cyt ) and serum (B gerum ) (Dale and Nilsen, 1986a) :
Concentrations of proteins were determined as described by Lowry and colleagues (1951) using bovine fraction V as standard.
Krebs-Ringer phosphate buffer pH 7.35 or pH 7.50 was used in all experiments Nilsen, 1984a, 1986a) .
Human serum was obtained by drawing blood from six non-fasted, non-smoking healthy volunteers who were not receiving any drugs (age 28-39 yr). Blood was allowed to clot for 2 h before centrifugation at 1100^ for lOmin. Serum was pooled and stored at -80 °C until use.
Rat liver cytosol was obtained from 20 non-fasted male Sprague-Dawley rats (weights 200-250 g) (Mallegard, Denmark). After decapitation of the rats the livers were immediately excised and homogenized in buffer at 4 °C. The first centrifugation was for 15 min at 12.000 #; thereafter, the supernatant was centrifuged at 105.000 g as previously described (Dale and Nilsen, 1984b 1 , purity > 98%) was delivered by New England Nuclear U.S.A. Isoflurane was obtained from Abbott, Norway. All chemicals were standard commercial products (pro analysis).
Statistics
Two-sample, two-tailed r-tests were used in all group comparisons, and P values less than 0.05 were considered significant. All lines were drawn by computer as least square regression lines.
RESULTS

Binding and serum albumin
Figure 1, plotted according to equation (2) demonstrates that isoflurane decreased the binding capacity of human serum albumin for diazepam at 23 °C. The values are given in table I, and it can be seen that the decreases in binding capacity were 70 and 81 % at isoflurane concentrations of 3.3% (3 MAC) and 5%, respectively. According to table I, isoflurane did not significantly affect the binding of phenytoin or warfarin under the conditions of the study.
Binding and distribution to serum and cytosol
The effects of 5 % isoflurane on the binding and distribution of the examined drugs to human serum and rat liver cytosol at 23 °C are presented in table II. Under these particular experimental conditions, isoflurane affected the binding of both diazepam and phenytoin, whereas there was no effect on the binding and distribution of warfarin. The binding of diazepam and phenytoin to serum was significantly reduced by about 55 % for both drugs; concomitantly, the binding of diazepam to proteins in cytosol was decreased by 36 %. On the other hand, isoflurane increased the cytosol: serum binding ratio of phenytoin by 133%. The free drug concentrations of diazepam and phenytoin in the presence of isoflurane (not given in table) increased by 82 and 59%, respectively.
Binding to serum Table III shows that isoflurane under clinically relevant conditions (1 MAC, 37 °C, serum) increased the free fractions of diazepam and phenytoin-by 16 and 11%, respectively. Isoflurane did not interact with the binding of warfarin to serum proteins.
DISCUSSION
The present study has shown that the volatile anaesthetic isoflurane is able to interact with the in vitro binding and distribution of drugs to proteins in serum and liver cell cytosol as shown earlier for halothane and enflurane Nilsen, 1984a, 1986a, b) .
In the previous studies it was suggested that the volatile anaesthetics affected the binding of diazepam to HSA more profoundly than that of phenytoin and warfarin Nilsen, 1984a, 1986b) . This observation was confirmed, as isoflurane markedly decreased the binding of diazepam to HSA, in contrast to its negligible impact on the binding of phenytoin and warfarin under the same conditions.
The studies on drug binding and distribution to serum and cytosol were performed over the same time scale for isoflurane, halothane and enflurane (Dale and Nilsen, 1986a) . Since identical biological material and isotopes were used, a comparison of the agents with respect to their ability to displace the drugs from protein is justified. The most striking feature was the similarity of drug-protein binding inhibition patterns exercised by the volatile anaesthetics. This was most clearly seen in the case of diazepam, which was displaced almost to the same extent from serum and cytosol by halothane, enflurane and isoflurane. However, enflurane was a more potent inhibitor of the binding of phenytoin than halothane and isoflurane (Dale and Nilsen, 1986b) . This comparison was based on equimolar concentrations in the air of the anaesthetics (5%). Since halothane has a higher blood/gas partition coefficient than enflurane and isoflurane (2.3, 1.8, 1.4, respectively) more halothane than enflurane and isoflurane will probably be present in the protein solution, suggesting that isoflurane and enflurane may be more potent inhibitors of drug protein binding than halothane.
The experiments performed at 37 °C with therapeutic drug concentrations and 1 MAC of the gases were undertaken to evaluate any possible clinical relevance of the present finding. This is especially important when anaesthetic gases are studied, since their solubility in serum decreases with increasing temperatures (Laasberg and Hedley-Whyte, 1970) . Based upon a comparison of the agents in regard to the drug most easily displaced, diazepam, it can be concluded that enflurane is the most significant "displacer" (Dale and Nilsen, 1984a) since the increases in the free fraction of diazepam in the presence of 1.7% enflurane and 1.1% isoflurane were 63 % and 16%, respectively, while no effect was exercised by 0.8 % halothane (Dale and Nilsen, 1984a) . The difference in effect between the isomers enflurane and isoflurane under these conditions may be explained by the higher MAC value and blood/gas partition coefficient of enflurane (Dripps, Eckenhoff and Vandam, 1977) which, in theory, may give a serum concentration of enflurane twice that of isoflurane and halothane at 1 MAC.
The 16% increase in the free fraction of diazepam in the presence of isoflurane is probably too small to be of clinical relevance. Therefore, it appears that only enflurane is capable of interacting with the binding of drug to serum protein to an extent that may have clinical significance (Dale and Nilsen, 1984a) . However, in vivo studies in man are needed to outline the significance of the proposed drug-volatile anaesthetic interaction (Flacke and Flacke, 1981) .
In conclusion, it has been shown that isoflurane interacts with the binding of drugs to serum protein in the same fashion as halothane and enflurane. However, the influence of isoflurane on the binding of the most easily displaced drug, diazepam, was too small to be of clinical significance.
